ASX:DRG

Draig Resources (DRG) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
179,850 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Draig Resources

Draig Resources Limited, together with its subsidiaries, engages in gold exploration activities. It holds 100% interests in the Bellevue gold project located to the north west of Laverton in Western Australia. The company was incorporated in 2004 and is based in West Perth, Australia.

DRG Stock News Headlines

ARCA PHARM INDEX
See More Headlines
Receive DRG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Draig Resources and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/15/2018
Today
4/25/2024

Industry, Sector and Symbol

Industry
Industrial Metals & Minerals
Sub-Industry
N/A
CIK
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. Stephen Andrew Parsons AusIMM
    Exec. Director
  • Mr. Michael Dylan Naylor B Com (Age 43)
    CA, AGIA, CFO & Company Sec.

DRG Stock Analysis - Frequently Asked Questions

How were Draig Resources' earnings last quarter?

Draig Resources Limited (ASX:DRG) released its quarterly earnings results on Thursday, March, 15th. The company reported ($0.01) earnings per share (EPS) for the quarter.

What other stocks do shareholders of Draig Resources own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Draig Resources investors own include Medicines (MDCO), Lithium Power International (LPI), KALA BIO (KALA), Immune Pharmaceuticals (IMNP), Auris Medical (EARS), Cytori Therapeutics (CYTX), Calyxt (CLXT), Alibaba Group (BABA) and Axsome Therapeutics (AXSM).

This page (ASX:DRG) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners